A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.
Completed · Not applicable · Has a placebo group
Conditions studied: Opioid Use Disorder
In brief
Investigators will test, for safety and efficacy, a novel treatment for opiate addiction that applies a 4-minute treatment of intense near infra-red light to stimulate a side of the brain that the investigators determine to be healthier, more mature, and less traumatized. Investigators will compare among actively using participants an active and a sham treatment given either once or twice weekly for 25-weeks at 2 sites. Investigators hope this will lead to a significant weapon in the battle against the opioid epidemic as well as lead to psychological and physiological insights into possible relations among trauma, cerebral laterality, and addiction.
Key facts
- Study ID
- NCT05995873
- Run by
- MindLight, LLC
- People needed
- 130
- Starts
- 2024-01-22
- Expected to finish
- 2025-11-17
- Last updated by the study team
- 2026-06-22
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Male or non-pregnant females between 18-65 years of age
- Individuals having an opioid use disorder with mild-to-severe symptoms
You may not qualify if…
- Individuals who are pregnant,
- Individuals who are psychotic,
- Individuals who are actively suicidal,
- Individuals who are a danger to self or others,
- Individuals who are who have a history of severe psychiatric or neurological disorders or life-threatening medical illness.
- Individuals will be excluded with chronic pain requiring opioid treatment.
- Individuals who are who are breastfeeding,
- Individuals who are adults requiring a legally authorized representative.
Where it is running
- MindLight, LLC — Newton Highlands, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.